A Phase II Trial of AEZS-108 in Castration- and Taxane-Resistant Prostate Cancer-Reference-Cited by-同舟云学术

A Phase II Trial of AEZS-108 in Castration- and Taxane-Resistant Prostate Cancer

Published:2017-12 Issue:6 Volume:15 Page:742-749
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Yu Steven S.,Athreya Kanthi,Liu Stephen V.,Schally Andrew V.,Tsao-Wei Denice,Groshen Susan,Quinn David I.,Dorff Tanya B.,Xiong Shigang,Engel Jurgen,Pinski Jacek

Funder

National Cancer Institute

National Institutes of Health

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference28 articles.

1. Chemohormonal therapy in metastatic hormone-sensitive prostate cancer;Sweeney;N Engl J Med,2015

2. American Society of Clinical Oncology endorsement of the Cancer Care Ontario Practice Guideline on nonhormonal therapy for men with metastatic hormone-refractory (castration-resistant) prostate cancer;Basch;J Clin Oncol,2007

3. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

4. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer;Petrylak;N Engl J Med,2004

5. Circumventing tumor resistance to chemotherapy by nanotechnology;Liang;Methods Mol Biol,2010

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Drug Conjugates in Cancer Therapy: Challenges and Opportunities;Pharmaceutical Science Advances;2024-08

2. A stochastically curtailed single‐arm phase II trial design for binary outcomes;Journal of Biopharmaceutical Statistics;2022-01-25

3. Peptide-based anticancer targeted therapeutics;Nanotherapeutics in Cancer Vaccination and Challenges;2022

4. Antitumor Activity and Mechanism of Action of Hormonotoxin, an LHRH Analog Conjugated to Dermaseptin-B2, a Multifunctional Antimicrobial Peptide;International Journal of Molecular Sciences;2021-10-20

5. Targeted paclitaxel‐octreotide conjugates inhibited the growth of paclitaxel‐resistant human non‐small cell lung cancer A549 cells in vitro;Thoracic Cancer;2021-10-06